Unrevealing the natural course of the so-called “inactive HBsAg or HBV carrier state” Stephanos J. Hadziyannis Editorial 02 June 2007 Pages: 281 - 284
Towards a rational treatment strategy for chronic hepatitis B Yun-Fan Liaw Editorial Notes 06 June 2007 Pages: 285 - 286
Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease Tatsuki IchikawaKazuhiko NakaoKatsumi Eguchi Original Paper 01 June 2007 Pages: 287 - 294
Changes in hepatic functional reserve after percutaneous tumor ablation for hepatocellular carcinoma: long-term follow up for 227 consecutive patients with a single lesion Yukihiro KoikeHaruhiko YoshidaMasao Omata Original Paper 08 June 2007 Pages: 295 - 301
Interferon-beta is activated by hepatitis C virus NS5B and inhibited by NS4A, NS4B, and NS5A Masaru MoriyamaNaoya KatoMasao Omata Original Paper 31 May 2007 Pages: 302 - 310
Spontaneous relapse of hepatitis in inactive HBsAg carriers Chia-Ming ChuYun-Fan Liaw Original Paper 09 June 2007 Pages: 311 - 315
Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategies George LauPatrick MarcellinMarion Peters Original Paper 06 June 2007 Pages: 316 - 325